Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Aequus Pharmaceuticals (AEQ) Stock Price & Analysis

AEQ Stock Chart & Stats

€0.01€0.00(20.00%)
At close: 5:30 PM GMT+1
€0.0115€0.01210 Aug24 Aug7 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
EUR 0.01 - EUR 0.01
52-Week Range
EUR 0.01 - EUR 0.01
Previous Close
EUR 0.01
Volume
N/A
Average Volume (3M)
10.00K
Market Cap
EUR 424.90K
Enterprise Value
EUR 7.21M
Total Cash (Recent Filing)
EUR 35.08K
Total Debt (Recent Filing)
EUR 6.64M
Price to Earnings (P/E)
3.1
Beta
0.91
Next Earnings
Dec 02, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The launch of ZIMED® PF has contributed to revenue growth, indicating successful product development and market acceptance, which can enhance long-term revenue streams.

Cost Management

Effective cost management through reduced general and administrative expenses can improve profitability and operational efficiency, supporting long-term financial health.

Product Pipeline

A robust product pipeline in niche markets like ophthalmology and transplant therapy positions Aequus for sustained growth by addressing unmet medical needs.

Bears Say

Financial Instability

Persistent financial instability with declining revenues and negative net income can hinder the company's ability to invest in growth and sustain operations long-term.

High Leverage

High leverage and negative equity pose risks to financial sustainability, limiting flexibility in financing growth initiatives and increasing vulnerability to economic downturns.

Leadership Changes

Frequent leadership changes can disrupt strategic continuity and affect long-term planning, potentially impacting the company's ability to execute its business strategy effectively.

Aequus Pharmaceuticals News

AEQ FAQ

What was Aequus Pharmaceuticals’s price range in the past 12 months?
Aequus Pharmaceuticals lowest stock price was €0.01 and its highest was €0.01 in the past 12 months.
What is Aequus Pharmaceuticals’s market cap?
Aequus Pharmaceuticals’s market cap is €424.90K.
When is Aequus Pharmaceuticals’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aequus Pharmaceuticals’s earnings last quarter?
Aequus Pharmaceuticals released its earnings results on Nov 28, 2025. The company reported €0.002 earnings per share for the quarter.
Is Aequus Pharmaceuticals overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Aequus Pharmaceuticals pay dividends?
Aequus Pharmaceuticals does not currently pay dividends.
What is Aequus Pharmaceuticals’s EPS estimate?
Aequus Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aequus Pharmaceuticals have?
Aequus Pharmaceuticals has 132,634,430 shares outstanding.
What happened to Aequus Pharmaceuticals’s price movement after its last earnings report?
Aequus Pharmaceuticals reported an EPS of €0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aequus Pharmaceuticals?
Currently, no hedge funds are holding shares in DE:AEQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology